Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance

American Journal of Physiology - Heart and Circulatory Physiology - Tập 293 Số 1 - Trang H583-H589 - 2007
Hanan Keren1, Daniel Burkhoff, Pierre Squara
1Cheetah Medical Limited, Ra'anana, Israel.

Tóm tắt

Noninvasive cardiac output (CO) measurement can be useful in many clinical settings where invasive monitoring is not desired. Bioimpedance (intrabeat measurement of changes in transthoracic voltage amplitude in response to an injected high-frequency current) has been explored for this purpose but is limited in some clinical settings because of inherently low signal-to-noise ratio. Since changes in fluid content also induce changes in thoracic capacitive and inductive properties, we tested whether a noninvasive CO measurement could be obtained through measurement of the relative phase shift of an injected current (i.e., bioreactance). We constructed a prototype device that applies a 75-kHz current and determines the relative phase shift (dΦ/d t) of the recorded transthoracic voltage. CO was related to the product of peak dΦ/d t, heart rate, and ventricular ejection time. The preclinical study was done in nine open-chest pigs put on right heart bypass so that CO could be varied at known values. This was followed by a feasibility study in 27 postoperative patients who had a Swan-Ganz catheter (SGC). The measurements of noninvasive CO measurement and cardiopulmonary bypass pump correlated to each other ( r = 0.84) despite the large variation in CO and temperatures. Similarly, in patients, mean CO values were 5.18 and 5.17 l/min as measured by SGC and the noninvasive CO measurement system, respectively, and were highly correlated over the range of values studied ( r = 0.90). Preclinical and clinical data demonstrate the feasibility of using blood flow-related phase shifts of transthoracic electric signals to perform noninvasive continuous CO monitoring.

Từ khóa


Tài liệu tham khảo

Albert NM, Hail MD, Li J, Young JB.Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure.Am J Crit Care13: 469–479, 2004.

10.1097/00003246-200003000-00016

10.1097/00003246-198610000-00017

10.1097/00003246-199422120-00005

Engoren M, Baebee D.Comparison of cardiac output determined by bioimpedance, thermodilution, and the Fick method.Am J Crit Care14: 40–45, 2005.

Fuller HD.The validity of cardiac output measurement by cardiothoracic impedance: a meta-analysis.Clin Invest Med15: 103–112, 1992.

10.1097/00003246-199505000-00014

10.1016/S0147-9563(05)80036-6

10.1097/00126097-200410000-00008

10.1097/00003246-199808000-00018

10.1097/00001573-200405000-00008

Nelson LD.The new pulmonary artery catheters: continuous venous oximetry, right ventricular ejection fraction, and continuous cardiac output.New Horiz5: 251–258, 1997.

10.1016/j.jacc.2005.12.071

Peacock WF, Summers RL, Vogel J, Emerman CE.Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT Trial.Acad Emerg Med13: 365–371, 2006.

10.1056/NEJMoa021108

10.1093/bja/aei224

10.1053/jcan.2001.26533

10.1378/chest.123.6.2028